SPARC and osteoarthritis: However, during estrogen withdrawal, osteoblasts secrete osteonectin (Sparc), which downregulates the expression of AMPK/FoxO3A in chondrocytes and promotes their hypertrophy and degeneration, ultimately leading to osteoarthritis (Jiang et al., 2023).